SUTENT (sunitinib malate) capsules, oral, Initial U.S. Approval: 2006. Available In India.

Sutent is a prescription medicine used to treat certain types of advanced or progressive tumors of the stomach, intestines, esophagus, pancreas, or kidneys. Brand SUTENT (sunitinib malate) Can be imported and made available on "Patient Name basis" treatment in India. If you have questions, please email IPN Support Team or Call Indian Pharma Network on +91 9891296838 (Mr. Tarun) / 9811747774 (Mr. Neeraj) for further details.

SUTENT (sunitinib malate) is used for the treatment of patients with renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST)

What SUTENT (sunitinib malate) is and What it is used for?

SUTENT is a kinase inhibitor indicated for the treatment of • Gastrointestinal stromal tumor (GIST) after disease progression on or intolerance to imatinib mesylate. • Advanced renal cell carcinoma (RCC). • Progressive, well-differentiated pancreatic neuroendocrine tumors (pNET) in patients with unresectable locally advanced or metastatic disease.

How to buy SUTENT (sunitinib malate) in India and overseas?

SUTENT (sunitinib malate) suppliers in India. Indian Pharma Network (IPN) New Delhi, INDIA.

IPN is a facilitator under Patient Assistance Programs. Expertise in Specialty Pharmaceutical distribution having its PAN India presence in Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, lucknow, north East and Pune and other cities in India. with over 20 years of domain experience.

For procurement cost of SUTENT (sunitinib malate) brand in India, sold by indian drug manufacturer. Please call at M: +91 9811747774 (Mr. Tarun) / 9891296838 (Mr. Neeraj) or Email Us to know more details about the SUTENT (sunitinib malate) medicine cost price in India.

The order for SUTENT (sunitinib malate) will be confirmed only after the receipt of valid prescription of doctor and import permit if applicable.

What Sunitinib is and What it is used for?

Sunitinib (marketed as Sutent by Pfizer, and previously known as SU11248) is an oral, small-molecule, multi-targeted receptor tyrosine kinase (RTK) inhibitor that was approved by the FDA for the treatment of renal cell carcinoma (RCC) and imatinib-resistant gastrointestinal stromal tumor (GIST) on January 26, 2006. Sunitinib was the first cancer drug simultaneously approved for two different indications

What are the brand names available for medicines containing Sunitinib?

SUTENT® (sunitinib malate) capsules, oral Initial U.S. Approval: 2006

Generic Name: sunitinib malate

Dosage Forms And Strengths of SUTENT (sunitinib malate).

Capsules: 12.5 mg, 25 mg, 50 mg.

GET IN TOUCH
with Indian Pharma Network

Indian Pharma Network, Delhi provides access to SUTENT (Sunitib) on the Named Patient Import basis in India.

Indian Pharma Network

60/4 1st Floor, T&T Building, Indian Oil Complex,
Yusuf Sarai, New Delhi, Delhi 110016

Mobile / WhatsApp / Phone

M: +91 9811747774, 9891296838.
P: +91-11-26532129 / 26536398

Free Customer Support

info@indianpharmanetwork.co.in
urgent@indianpharmanetwork.co.in

SUTENT (sunitinib malate) suppliers in India

IPN helps patients, doctors and hospitals as a facilitator to import prescription medicine brand SUTENT (sunitinib malate) on prescription and Import License in Patient's Name only.

For overseas patients, SUTENT (sunitinib malate) can be made available in Send your enquiry to find SUTENT (sunitinib malate) in China, Cambodia, Indonesia, Malaysia, the Philippines, Singapore, Thailand, Vietnam, Hong Kong. UAE Iraq, Iran, Saudi Arabia, Jordan, Mexico, Argentina, Brazil, Chile, Colombia, Peru, Venezuela. Europe – Romania, Switzerland, Georgia, Turkey, Italy, UK, Ukraine, Azerbaijan, Latvia, Poland, Slovakia. Russia CIS – Armenia, Kazakhstan, Moldova, Tajikistan, Turkmenistan, Uzbekistan, Mongolia, Algeria, Mauritius, Uganda, Zimbabwe. Australia and New Zealand.

News / Update for SUTENT (sunitinib malate).

For SUTENT (sunitinib malate) Indications And Usage, Dosage And Administration, Dosage Forms And Strengths and Drug Interactions For More Details

FDA expands approval of Sutent to reduce the risk of kidney cancer returning For More Details

Immunotherapy Brings More Options for Frontline RCC Treatment For More Details

Get Access To FDA Approved Drug SUTENT (sunitinib malate) capsules In India

Indian Pharma Network (IPN), Delhi India is a leading Pharmaceutical Distributor / Supplier / Exporter / Importer of Anti-Cancer Medicines, used in for the adjuvant treatment of adult patients at high risk of recurrent RCC following nephrectomy treatment. Brand Name "SUTENT (sunitinib malate) capsules" or Generic Name "Sunitinib malate capsules" can be imported for personal use under "patient name basis" treatment in Delhi, Mumbai, Kolkata, Chennai, Bangalore, Hyderabad, Ahmedabad, Pune, Surat, Jaipur, Coimbatore, Noida, Gurgaon, Punjab, Chandigarh, Bhubaneswar, Arunachal Pradesh, Assam, Manipur, Meghalaya, Mizoram, Nagaland, Tripura and Sikkim, India. Contact us at urgent@indianpharmanetwork.co.in or call/WhatsApp at +91 9891296838 / 9811747774 to get access as per norms.